Since the cell viability assay has confirmed that compound 10 could dose-dependently inhibit the growth of colorectal cancer cells, an annexin V assay was conducted to further identify the cell death type in colon cancer cells. This evidence concerns the gene ANXA5 and colonic neoplasm.